News and Activities
Hot Off The Press.
Press Releases
Straticyte™ Abstract Selected for Presentation at the AHNS 10th International Conference on Head and Neck Cancer
MaRS Discovery District, Toronto, ON; March 31, 2021 - Proteocyte AI, a personalized medicine and diagnostics company located at MaRS Centre, Toronto, ON, announces today that an abstract and poster titled “Assessing Risk of Oral Cancer Progression Using an S100A7 Immunohistochemical...
First International Clinical Advisory Board Meeting
MaRS Discovery District, Toronto, ON; January 18, 2021 - Proteocyte AI, a personalized medicine and diagnostics company located in MaRS Center, Toronto ON, announces today that the first Clinical Advisory Board (CAB) meeting with some of the most renowned global key opinion leaders in oral cancer...
New Management and Clinical Advisory Board
MaRS Discovery District, Toronto, ON; January 8, 2021 - Proteocyte AI, a personalized medicine and diagnostics company located in MaRS Center, Toronto ON, announces today that the company has hired a new management team, led by seasoned MedTech entrepreneur Steve Arless of Montreal as Executive...
Incorporating Straticyte™ Could Enhance Assessment of Cancer Risk in Oral Lesions
MaRS Discovery District, Toronto, ON; December 14, 2020 - Proteocyte AI, a personalized medicine and diagnostics company located in MaRS Centre, Toronto, ON, announces today that Oral Cancer and the Race Against Time: Use of Psoriasin (S100A7) as a Predictive Marker to Enhance Assessment of Cancer...